Geriatric oncology focuses on tailoring cancer treatment strategies to meet the specific needs of older adults, who often have distinct physiological responses to therapy. Older patients may experience unique side effects due to frailty, comorbidities, and polypharmacy. Therefore, treatments should be personalized to balance effectiveness with minimizing adverse effects. The use of geriatric assessments to evaluate physical, cognitive, and psychosocial factors is critical in guiding treatment decisions. A multidisciplinary approach, involving oncologists, geriatricians, and other specialists, ensures that therapies are appropriate, thus improving the quality of life and survival for elderly cancer patients.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China